Fig. 2From: The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patientsResponse to induction therapy. The OS was significantly conditioned by the response to therapy, with the median not reached at 12 months by patients in CR compared to only 3 months for those who achieved only a PR or did not respond to treatment (p < 0.001) (a). Also EFS was significantly conditioned, with 43% of patients in CR who were free from events at 12-months versus 18% of those who did not reach a complete response (p < 0.001) (b)Back to article page